New Drug Research and Development Center, NatureWise Biotech and Medicals Corporation, Taipei 115, Taiwan.
J Agric Food Chem. 2012 Jun 20;60(24):6139-49. doi: 10.1021/jf300815b. Epub 2012 Jun 7.
Royal jelly (RJ) is a widely used natural food. It is also a major source of nutrition for queen bees and plays a key role in their development. RJ is secreted from the hypopharyngeal and mandibular glands of young adult worker bees. The regulation of gene expression in these two glands may influence the development of queen bees by affecting the content of RJ. This study investigated the epigenetic effects in these two glands in young adult worker bees treated with histone deacetylase inhibitors (HDACis), a U.S. Food and Drug Administration-approved drug, suberoylanilide hydroxamic acid (SAHA), and NBM-HD-1, a novel compound synthesized in this laboratory. Western blot analyses indicated that the levels of acetyl-histone 3 and p21 protein expression in MCF-7 cells increased markedly after treatment with NBM-HD-1. The data proved that NBM-HD-1 was a novel and potent HDACi. Furthermore, a method of affecting epigenetic regulation of the mrjp family gene in the hypopharyngeal and mandibular glands of young adult worker bees was developed by feeding young adult worker bees HDACi. Epigenetic regulation produced several important biological effects. A marked change in the protein composition of the RJ secreted from these treated bees was found. Only the ratio of specific major royal jelly protein 3 (MRJP3) was significantly altered in the treated bees versus the untreated controls. Other MRJP family proteins did not change. This alteration in the ratio of royal jelly proteins resulted in a significant increase in the body size of queen bee larvae. The data seem to suggest that HDACis may play an important role in the epigenetic regulation of the hypopharyngeal and mandibular glands of young adult worker bees. They appear to change mrjp3 gene expression and alter the ratio of MRJP3 protein in RJ. This study presents the first evidence that HDACis are capable of regulating the ratio of MRJP3 proteins in RJ, which has the potential to change the body size of queen bees during their development.
蜂王浆(RJ)是一种广泛使用的天然食品。它也是蜂王的主要营养来源,对其发育起着关键作用。RJ 是由年轻成年工蜂的咽下腺和下颌腺分泌的。这两个腺体中基因表达的调节可能通过影响 RJ 的含量来影响蜂王的发育。本研究调查了年轻成年工蜂在接受组蛋白去乙酰化酶抑制剂(HDACi)、美国食品和药物管理局批准的药物 SAHA 和本实验室合成的新型化合物 NBM-HD-1 治疗后这两个腺体中的表观遗传效应。Western blot 分析表明,在用 NBM-HD-1 处理 MCF-7 细胞后,乙酰化组蛋白 3 和 p21 蛋白的表达水平明显增加。数据证明 NBM-HD-1 是一种新型有效的 HDACi。此外,通过喂食年轻成年工蜂 HDACi,开发了一种影响年轻成年工蜂咽下腺和下颌腺中 mrjp 家族基因表观遗传调控的方法。表观遗传调控产生了一些重要的生物学效应。发现从这些处理过的蜜蜂分泌的 RJ 中的蛋白质组成发生了明显变化。仅在处理过的蜜蜂中,特定的主要蜂王浆蛋白 3(MRJP3)的比例与未处理的对照组相比发生了显著改变。其他 MRJP 家族蛋白没有变化。这种蜂王浆蛋白比例的改变导致蜂王幼虫的体型显著增大。数据似乎表明,HDACi 可能在年轻成年工蜂咽下腺和下颌腺的表观遗传调控中发挥重要作用。它们似乎改变了 mrjp3 基因的表达,并改变了 RJ 中 MRJP3 蛋白的比例。本研究首次证明 HDACi 能够调节 RJ 中 MRJP3 蛋白的比例,这有可能改变蜂王在发育过程中的体型。